Hypertension remains the silent killer in patients with CKD healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Anti-hypertensive agents are still the treatment drugs for hypertension but recent advances indicate that combination therapy may be a more effective form of treatment.
This feature articles commemorates the 10-year anniversary of the FDA's first approval of an SGLT2 inhibitor on March 29, 2013 and provides a snapshot at the class's ascent into the treatment algorithms and guidelines for type 2 diabetes, heart failure, and chronic kidney disease.
Among patients with type 2 diabetes and albuminuric chronic kidney disease, canagliflozin reduced kidney and cardiovascular events independent of age or sex, according to data published in the American Journal of Kidney Diseases. Tae Won Yi, MD, from the George Institute for Global Health at the University of New South Wales in Australia, and colleagues examined 4,401 patients with type 2
Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease asnjournals.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asnjournals.org Daily Mail and Mail on Sunday newspapers.